Description
THIS MODIFICATION IS ISSUED TO INCORPORATE NOVO NORDISK'S 2025 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF JANUARY 1, 2025 - DECEMBER 31, 2025.
Base award description: NEW NATIONAL CONTRACT AWARD FOR SEMAGLUTIDE INJ SOLN (OZEMPIC) WITH NOVO NORDISK. PERIOD OF PERFORMANCE IS 11/02/2020 THROUGH 11/01/2021 WITH FOUR ONE-YEAR OPTION PERIODS.
First action · last action
2020-09-22 · 2025-04-02
Transactions
20
First transaction's obligation
$0
Base + all options value (sum of deltas)
$598,189,800
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 20 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-09-22+$0= $0
- Mod P000012020-11-20+$0= $0
- Mod P000022020-12-09+$0= $0
- Mod P000032021-03-24+$0= $0
- Mod P000042021-09-22+$0= $0
- Mod P000052021-12-13+$0= $0
- Mod P000062021-12-20+$0= $0
- Mod P000072022-09-15+$0= $0
- Mod P000082022-12-15+$0= $0
- Mod P000092022-12-30+$0= $0
- Mod P000102023-03-13+$0= $0
- Mod P000112023-05-11+$0= $0
- Mod P000122023-10-25+$0= $0
- Mod P000132023-10-30+$0= $0
- Mod P000142024-02-27+$0= $0
- Mod P000152024-02-29+$0= $0
- Mod P000162024-04-04+$0= $0
- Mod P000172024-10-01+$0= $0
- Mod P000182024-12-20+$0= $0
- Mod P000192025-04-02+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-09-22 | +$0 | $0 | NEW NATIONAL CONTRACT AWARD FOR SEMAGLUTIDE INJ SOLN (OZEMPIC) WITH NOVO NORDISK. PERIOD OF PERFORMANCE IS 11… |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2020-11-20 | +$0 | $0 | INCORPORATE FEDERAL CEILING PRICE IAW PUBLIC LAW 102-585 FOR SEMAGLUTIDE INJ SOLN (OZEMPIC) WITH NOVO NORDISK.… |
| Mod P00002· ADD SUBCONTRACTING PLAN | 2020-12-09 | +$0 | $0 | INCORPORATION OF 2021 NOVO NORDISK SUBCONTRACTING PLAN EFFECTIVE 01/01/2021 THROUGH 12/31/2021. |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2021-03-24 | +$0 | $0 | ADD A NEW PRODUCT ADDITION THAT WILL REPLACE .THE 1MG DOSE 2 PENS (1.5ML EA) WITH 1 - 3ML PEN. EFFECTIVE DATE… |
| Mod P00004· EXERCISE AN OPTION | 2021-09-22 | +$0 | $0 | EXERCISE THE FIRST OPTION YEAR FOR NOVO NORDISK NATIONAL CONTRACT FOR OZEMPIC. NEW CONTRACT PERIOD IS 11/02/20… |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-13 | +$0 | $0 | 2022 FCP OZEMPIC NOVO NORDISK |
| Mod P00006· ADD SUBCONTRACTING PLAN | 2021-12-20 | +$0 | $0 | INCORPORATE 2022 NOVO NORDISK SUBCONTRACTING PLAN EFFECTIVE 01/01/2022 - 12/31/2022. |
| Mod P00007· EXERCISE AN OPTION | 2022-09-15 | +$0 | $0 | EXERCISE 2ND OPTION YEAR FOR NOVO NORDISK CONTRACT FOR OZEMPIC EFFECTIVE 11/02/2022 - 12/31/2022. |
| Mod P00008· ADD SUBCONTRACTING PLAN | 2022-12-15 | +$0 | $0 | FAR 52.219-9 SMALL BUSINESS SUBCONTRACTING PLAN. IMPLEMENT NOVO NORDISK, INC. 2023 SUBK PLAN. |
| Mod P00009· OTHER ADMINISTRATIVE ACTION | 2022-12-30 | +$0 | $0 | INCORPORATE 2023 FCP PRICING |
| Mod P00010· OTHER ADMINISTRATIVE ACTION | 2023-03-13 | +$0 | $0 | NDC ADDITION TO 36E79720D0071 WITH NO PRICE CHANGE. PERIOD OF PERFORMANCE IS EFFECTIVE 03/13/2023-11/01/2023.… |
| Mod P00011· OTHER ADMINISTRATIVE ACTION | 2023-05-11 | +$0 | $0 | UNILATERAL MODIFICATION IS ISSUED TO INCORPORATE UPDATED DSCSA LANGUAGE AND REQUIREMENTS INTO VA NATIONAL CONT… |
| Mod P00012· OTHER ADMINISTRATIVE ACTION | 2023-10-25 | +$0 | $0 | NDC DELETION TO 36E79720D0071. NDC 00169-4132-12 HAS BEEN FULLY DEPLETED AND DELETED ON 10/25/2023. |
| Mod P00013· EXERCISE AN OPTION | 2023-10-30 | +$0 | $0 | EXERCISE 3RD OPTION YEAR FOR NOVO NORDISK CONTRACT 36E79720D0071 FOR OZEMPIC EFFECTIVE 11/02/2023 - 11/01/2024… |
| Mod P00014· ADD SUBCONTRACTING PLAN | 2024-02-27 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE NOVO NORDISK'S 2024 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF… |
| Mod P00015· OTHER ADMINISTRATIVE ACTION | 2024-02-29 | +$0 | $0 | 2024 FCP UPDATES |
| Mod P00016· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-04-04 | +$0 | $0 | MODIFICATION FOR THE SUPPLEMENTAL CHANGES TO THE CRF PAYMENT SUBMITTAL AND SALES REPORTING REQUIREMENTS. |
| Mod P00017· EXERCISE AN OPTION | 2024-10-01 | +$0 | $0 | EXERCISE 4TH OPTION YEAR FOR NOVO NORDISK CONTRACT 36E79720D0071 FOR OZEMPIC EFFECTIVE 11/02/2024 - 11/01/2025… |
| Mod P00018· OTHER ADMINISTRATIVE ACTION | 2024-12-20 | +$0 | $0 | INCORPORATE FEDERAL CEILING PRICE IAW PUBLIC LAW 102-585 FOR SEMAGLUTIDE INJ SOLN (OZEMPIC) WITH NOVO NORDISK.… |
| Mod P00019· ADD SUBCONTRACTING PLAN | 2025-04-02 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE NOVO NORDISK'S 2025 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI W72BJMJYBMN3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79725A0025 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36F79721D0044 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36E79720D0018 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2020 |
| 36F79719D0181 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2019 |
| VA797P15C0039 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2015 |
| VA24113F0882 | 241-NETWORK CONTRACT OFFICE 01 · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2013 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79720D0071_3600 · retrieved 2026-09-26.